RE:RE:RE:RE:AGM notesAttended as well.
i would say there were no surprises.
it was nice to chat to a few people.
i would echo the positive sentiments about Shawn. I was very impressed with him.
it was nice to see that the focus is full steam ahead on one indication before getting too tied up with other indications.
Both the new CEO’s were front and center with Arcady for questions but you could tell that Roger still has plenty of influence.
of note, the fiberoptic assembly has been manufactured down to a 1.9 fr size which would allow eventual clinic style treatment which would expand upon the market for the technical division. Obviously further down the road, but interesting.
macer